Pain News and Research

Latest Pain News and Research

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

CTI BioPharma Corp. and Baxter International Inc. today announced positive top-line results for the primary endpoint from PERSIST-1, the randomized, controlled Phase 3 registration clinical trial examining pacritinib, a next generation oral JAK2/FLT3 multikinase inhibitor, for the treatment of patients with primary or secondary myelofibrosis.

From Baxter International Inc. 9 Mar 2015

BMC researchers to play key role in examining best treatment for acute low back pain

Boston Medical Center researchers are part of a national clinical trial that will examine how best to treat acute low back pain and potentially prevent it from being chronic. BMC will receive $2.3 million for its role in the five-year study that was recently approved for a $14 million award by the Patient-Centered Outcomes Research Institute.

9 Mar 2015

Obese older adults have higher rate of hospitalizations, ER admissions

Obesity is associated with substantial increases in older adults' hospitalizations, emergency room admissions and use of outpatient health care services, according to a new study of 172,866 Medicare Advantage members throughout the U.S.

9 Mar 2015

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).

8 Mar 2015

Researchers study safety, effectiveness of experimental Ebola vaccine following high-risk exposure

A physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone did not develop Ebola virus infection, and there was strong Ebola-specific immune responses after the vaccination, although because of its limited use to date, the effectiveness and safety of the vaccine is not certain, according to a study appearing in JAMA.

6 Mar 2015

AAPMD announces "The Silent Airway Problem: Connecting the Dots" conference

The American Academy of Physiological Medicine and Dentistry (AAPMD) is leading the charge for an interdisciplinary medical approach to the diagnosis and treatment of sleep and breathing disorders, which research indicates contribute to a range of serious physiological, cognitive, behavioral and performance conditions in children and adults.

6 Mar 2015

Non-viral gene therapy provides relief for diabetics with constant foot pain

Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.

6 Mar 2015

83% of British people recognise that chronic pain is a serious medical condition, however only 15% receive proper treatment

Almost ten million people in the UK suffer from chronic pain, which has a major impact on quality of life and day to day activities, such as work; however many of those people do not have their pain under control or know how to go about seeking the right treatment.

5 Mar 2015

Good news for patients suffering from shingles

The Journal of Drugs in Dermatology is delighted to present new findings from the Mayo Clinic's Department of Dermatology showing possible relief from the complications and pain secondary to Herpes Zoster, commonly known as shingles.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

The Valley Hospital today announced it was the first hospital in New Jersey to use a recently approved device to offer a minimally-invasive approach to the treatment of peripheral artery disease (PAD) in the upper leg, a serious and common condition associated with an increased risk for heart attack and stroke.

5 Mar 2015

Accidental fentanyl exposure in children can be fatal

Infants and children are at a higher risk of accidental exposure to fentanyl patches—adhesive patches used to deliver higher doses of some opiates through the skin to relieve chronic pain.

4 Mar 2015

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

Southern Maryland's first modern medical resort officially opened its doors with a ribbon-cutting ceremony on February 27.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis.

4 Mar 2015

$New guidance to prevent bisphosphonate-related atypical femoral fractures$

New guidance to prevent bisphosphonate-related atypical femoral fractures

Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ibandronate (Boniva) to treat osteoporosis and prevent fragility fractures. Unfortunately, long-term bisphosphonate use has been linked to an increased risk of atypical femoral fractures.

4 Mar 2015

NHS savings plan led to cuts in some ‘ineffective’ treatments

The drive to reduce NHS spending led to a drop in some treatments considered ‘low-value’, according to new research.

4 Mar 2015

Non-drug approaches work better in people with Alzheimer's disease, dementia

Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer's disease and other types of dementia. But non-drug approaches actually work better, and carry far fewer risks, experts conclude in a new report.

4 Mar 2015

Study on spider venom may lead to new class of potent painkillers

New research shows that seven compounds of the countless found in spider venom block a key step in the body's ability to pass pain signals to the brain. The hunt for a medicine based on just one of these compounds, which would open up a new class of potent painkillers, is now a step closer according to new research published in the British Journal of Pharmacology.

4 Mar 2015

Study finds link between fluoridated water and ADHD prevalence

"Artificial water fluoridation prevalence was significantly positively associated with ADHD prevalence," according to research published in Environmental Health (2/15), reports the Fluoride Action Network (FAN).

3 Mar 2015

Pain News and Research

Latest Pain News and Research

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

BMC researchers to play key role in examining best treatment for acute low back pain

Obese older adults have higher rate of hospitalizations, ER admissions

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Researchers study safety, effectiveness of experimental Ebola vaccine following high-risk exposure

AAPMD announces "The Silent Airway Problem: Connecting the Dots" conference

Non-viral gene therapy provides relief for diabetics with constant foot pain

83% of British people recognise that chronic pain is a serious medical condition, however only 15% receive proper treatment

Good news for patients suffering from shingles

Mallinckrodt enters into definitive agreement to acquire Ikaria

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

Accidental fentanyl exposure in children can be fatal

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

New guidance to prevent bisphosphonate-related atypical femoral fractures

NHS savings plan led to cuts in some ‘ineffective’ treatments

Non-drug approaches work better in people with Alzheimer's disease, dementia

Study on spider venom may lead to new class of potent painkillers

Study finds link between fluoridated water and ADHD prevalence

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in